Almac Diagnostic Services
Your global partner for biomarker discovery, development & commercialization.
We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.Find out more
Clinical Trial Assays
Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.Find out more
A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialization services.Find out more
Almac offers a unique business model to our clients, providing complete flexibility to support the strategies required to deliver precision medicine. We offer a range of platform and chemistry options, across many different sample types and disease indications so you are not tied to one solution and will always have the freedom to move. We also have a range of innovative proprietary biomarker discovery software reporting solutions that our partners can access to support novel analysis of their data.
We enable our partners to rapidly take their drug and biomarker into clinical trials whilst supporting an evolving program with expert advice and guidance along the way.
Commercially, we can support single site and IVD kit companion diagnostic development. We are also flexible on the downstream commercialization strategy where we can manufacture and market your assay, or we can support the transition of the CDx to an alternative commercial company.
Almac Diagnostic Services has highly experienced teams (Scientific, Regulatory, Data Sciences, Medical and Commercial), with a reputation for quality and a highly collaborative approach.
We will become an extension of your team, who you can trust to ensure the success of your project.
Discover Almac Diagnostic Services
View some of our partners
Almac Diagnostic Services Testimonials
“Your Project Managers have been tremendous support for all of the ups and downs with our Drug Program. It may seem a small thing but it was terrific to feel as though they were allies rather than adversaries as we worked together. Their hard work has garnered my deep gratitude and more importantly an excellent reputation for Almac within our Company. Reflecting on how adaptable they were to all of the challenges we faced made it very easy to recommend that we partner with Almac for upcoming work ………. your Project Managers definitely deserve to be commended for all that they’ve done.”
Global Pharma Company
“Please convey to Almac what an incredible job your lab staff did. Everything about the validation preparation, and in particular, the output and documentation is excellent – depth of content, quality of the writeup, inclusion of exceptions tables, executive summaries, clear reference to tables & figures. In addition, the supporting data files are clean, well-structured, comprehensive, and enable exploration and resolution of any possible questions we might have about assay performance over the course of this validation. This is one of the best validations I’ve ever reviewed from Almac, and I’d like to thank you for all your hard work and emphasize that it’s made a positive impact on us as a client. Kudos to your team!”
Global Pharma Company
“We started using Almac Diagnostic Services because the lab that had been running our assay for 5 years was no longer going to support our assay. I worked very well with this other lab and was concerned about having to change. However, Almac Diagnostic Services made this transition very easy. It was a pleasurable experience and I hope I get the chance to work with Almac Diagnostic Services again.”
“I just wanted to take a moment and thank you all and the extended Almac Diagnostic Services team for an awesome job in completing the IDE submission in record time. At times it looked really challenging, unrealistic and too cumbersome a process but the team did a great job despite all the odds.”
Latest eventsSee all Events
ASCO 20232 Jun 2023 Chicago, ILEvent Details
ESMO 202320 Sep 2023 Madrid, SpainEvent Details
May 17, 2023Read more
Almac Diagnostic Services updates claraᵀ report with significant new content for cancer research
August 11, 2022Read more
Almac, AstraZeneca CDx Partnership Branching Out to New Disease Areas, Drawing on NGS, qPCR
June 23, 2022Read more
Almac Diagnostic Services collaborates with AstraZeneca to Develop and Commercialize Companion Diagnostics (CDx)
December 8, 2021Read more
Almac Diagnostic Services’ claraT Report Assists Researchers In Uncovering New Oncology Findings